Effects of oral administration of bezafibrate on peroxisomes and carnitine acetyltransferase in rat hepatocytes.
暂无分享,去创建一个
[1] D. Valle,et al. The 70 kDa peroxisomal membrane protein: an ATP-binding cassette transporter protein involved in peroxisome biogenesis. , 1993, Seminars in cell biology.
[2] R Kato,et al. Sex-specific cytochrome P450 as a cause of sex- and species-related differences in drug toxicity. , 1992, Toxicology letters.
[3] H. Takebe. Morphological changes in the hepatocyte peroxisomes by age in mice administered with an anti-hyperlipidemic agent,clofibrte , 1992 .
[4] K. Alberti,et al. Clofibrate induces carnitine acyltransferases in periportal and perivenous zones of rat liver and does not disturb the acinar zonation of gluconeogenesis. , 1989, Biochimica et biophysica acta.
[5] Yamada Junji,et al. Species differences in the effects of bezafibrate, a hypolipidemic agent, on hepatic peroxisome-associated enzymes. , 1989 .
[6] K. Beier,et al. Selective induction of peroxisomal enzymes by the hypolipidemic drug bezafibrate. Detection of modulations by automatic image analysis in conjunction with immunoelectron microscopy and immunoblotting. , 1988, European journal of cell biology.
[7] C. Henninger,et al. Effects of fenofibrate treatment on fatty acid oxidation in liver mitochondria of obese Zucker rats. , 1987, Biochemical pharmacology.
[8] J. Bar-Tana,et al. Adipocyte conversion of cultured 3T3-L1 preadipocytes by bezafibrate. , 1987, Life sciences.
[9] J. Bar-Tana,et al. Adipose conversion of cultured rat primary preadipocytes by hypolipidemic drugs. , 1986, Biochimica et biophysica acta.
[10] T. Kamataki,et al. Postnatal development of constitutive forms of cytochrome P-450 in liver microsomes of male and female rats. , 1984, Biochemical pharmacology.
[11] T. Kamataki,et al. Sex difference of cytochrome P-450 in the rat: purification, characterization, and quantitation of constitutive forms of cytochrome P-450 from liver microsomes of male and female rats. , 1983, Archives of biochemistry and biophysics.
[12] P. Lazarow. Catabolic Functions of Peroxisomes: Modification by Hypoupidemic Drugs , 1983 .
[13] T. Hashimoto,et al. Purification and properties of carnitine acetyltransferase from rat liver. , 1983, Journal of biochemistry.
[14] A. Reinicke,et al. THE SHORT‐ AND LONG‐TERM EFFECTS OF BEZAFIBRATE IN THE RAT * , 1982, Annals of the New York Academy of Sciences.
[15] B. Lake,et al. Peroxisome proliferation in cultured rat hepatocytes produced by clofibrate and phthalate ester metabolites. , 1982, Toxicology letters.
[16] J. Reddy,et al. Immunochemical identity of peroxisomal enoyl-CoA hydratase with the peroxisome-proliferation -associated 80,000 mol wt polypeptide in rat liver , 1981, The Journal of cell biology.
[17] J. Reddy,et al. Hypolipidaemic hepatic peroxisome proliferators form a novel class of chemical carcinogens , 1980, Nature.
[18] N. Tolbert,et al. Comparison of the carnitine acyltransferase activites from rat liver peroxisomes and microsomes. , 1976, Archives of biochemistry and biophysics.
[19] N. Tolbert,et al. The subcellular distribution of carnitine acyltransferases in mammalian liver and kidney. A new peroxisomal enzyme. , 1973, The Journal of biological chemistry.
[20] Svoboda Dj,et al. Effects of selected hypolipidemic drugs on cell ultrastructure. , 1971 .
[21] R. Barrnett,et al. Cytochemical localization of transferase activities: carnitine acetyltransferase. , 1970, Journal of cell science.
[22] M. Chiga,et al. MICROBODIES IN EXPERIMENTALLY ALTERED CELLS , 1970, The Journal of cell biology.
[23] R. Hess,et al. NATURE OF THE HEPATOMEGALIC EFFECT PRODUCED BY ETHYL-CHLOROPHENOXY-ISOBUTYRATE IN THE RAT , 1965, Nature.